0001104659-21-027293.txt : 20210224
0001104659-21-027293.hdr.sgml : 20210224
20210224114235
ACCESSION NUMBER: 0001104659-21-027293
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200215
FILED AS OF DATE: 20210224
DATE AS OF CHANGE: 20210224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leen Ann M.
CENTRAL INDEX KEY: 0001763026
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37939
FILM NUMBER: 21670142
MAIL ADDRESS:
STREET 1: 5 WEST FORSYTH STREET
STREET 2: SUITE 200
CITY: JACKSONVILLE
STATE: FL
ZIP: 32202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Marker Therapeutics, Inc.
CENTRAL INDEX KEY: 0001094038
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880277072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: (713) 400-6400
MAIL ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC.
DATE OF NAME CHANGE: 20170629
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC
DATE OF NAME CHANGE: 20070628
FORMER COMPANY:
FORMER CONFORMED NAME: GENEMAX CORP
DATE OF NAME CHANGE: 20020718
4
1
tm217831d1_form4.xml
FORM 4
X0306
4
2020-02-15
1
0001094038
Marker Therapeutics, Inc.
MRKR
0001763026
Leen Ann M.
3200 SOUTHWEST FREEWAY,
SUITE 2500
HOUSTON
TX
77027
0
1
0
0
Chief Scientific Officer
The reporting person resigned as Chief Scientific Officer February 15, 2021. As a result, the reporting person was no longer an officer of the Issuer and was thereafter no longer subject to Section 16 in connection with her transactions in the equity securities of the Issuer and will no longer report any such transactions on Form 4 or Form 5.
/s/ Mark A. Catchur, as Attorney-in-Fact for Ann M. Leen
2021-02-24